What it is:
This is actually a set of several funding calls spread over both 2014 and 2015, with the following cute names:
They all fit under the equally cute “H2020-PHC-2014-2015”, and under the general concept of “personalising health and care”. Reading the work programme (warning: quite long!) you can see that they want people to address the following many topics:
- PHC 1 – 2014: Understanding health, ageing and disease: determinants, risk factors and pathways (€4-6m per proposal)
- PHC 2 – 2015: Understanding diseases: systems medicine (€4-6m per proposal)
- PHC 3 – 2015: Understanding common mechanisms of diseases and their relevance in co-morbidities (same again)
- PHC 4 – 2015: Health promotion and disease prevention: improved inter-sector cooperation for environment and health based interventions (€4-6m again)
- PHC 5 – 2014: Health promotion and disease prevention: translating ‘omics’ into stratified approaches (you guessed it)
- PHC 6 – 2014: Evaluating existing screening and prevention programmes (€different! 2-3m per proposal)
- PHC 7 – 2014: Improving the control of infectious epidemics and foodborne outbreaks through rapid identification of pathogens (€15-20m per proposal)
- PHC 8 – 2014: Vaccine development for poverty-related and neglected infectious diseases: Tuberculosis (€15-25m)
- PHC 9 – 2015: Vaccine development for poverty-related and neglected infectious diseases: HIV/AIDS (€15-20m)
- PHC 10 – 2014: Development of new diagnostic tools and technologies: in vitro devices, assays and platforms (€4-6m)
- PHC 11 – 2015: Development of new diagnostic tools and technologies: in vivo medical imaging technologies (€4-6m)
- PHC 12 – 2014/2015: Clinical research for the validation of biomarkers and/or diagnostic medical devices (phase 1: €50k, phase 2: €1-5m)
- PHC 13 – 2014: New therapies for chronic non-communicable diseases (€4-6m)
- PHC 14 – 2015: New therapies for rare diseases (€4-6m)
- PHC 15 – 2014/2015: Clinical research on regenerative medicine (€4-6m)
- PHC 16 – 2015: Tools and technologies for advanced therapies (€4-6m)
- PHC 17 – 2014: Comparing the effectiveness of existing healthcare interventions in the elderly (€4-6m)
- PHC 18 – 2015: Establishing effectiveness of health care interventions in the paediatric population (€4-6m)
- PHC 19 – 2014: Advancing active and healthy ageing with ICT: Service robotics within assisted living environments (€3-4m)
- PHC 20 – 2014: Advancing active and healthy ageing with ICT: ICT solutions for independent living with cognitive impairment (€2-3m)
- PHC 21 – 2015: Advancing active and healthy ageing with ICT: Early risk detection and intervention (€3-4m)
- PHC 22 – 2015: Promoting mental wellbeing in the ageing population (€4-6m)
- PHC 23 – 2014: Developing and comparing new models for safe and efficient, prevention oriented health and care systems (€4-6m)
- PHC 24 – 2015: Piloting personalised medicine in health and care systems (€12-15m)
- PHC 25 – 2015: Advanced ICT systems and services for Integrated Care (€3-5m)
- PHC 26 – 2014: Self-management of health and disease: citizen engagement and mHealth (€3-5m)
- PHC 27 – 2015: Self-management of health and disease and patient empowerment supported by ICT (€3-5m)
- PHC 28 – 2015: Self-management of health and disease and decision support systems based on predictive computer modelling used by the patient him or herself (€3-5m)
- PHC 29 – 2015: Public procurement of innovative eHealth services (€1-5m)
- PHC 30 – 2015: Digital representation of health data to improve disease diagnosis and treatment (€3-5m)
- PHC 31 – 2014: Foresight for health policy development and regulation (€2-3m)
- PHC 32 – 2014: Advancing bioinformatics to meet biomedical and clinical needs (€2-3m)
- PHC 33 – 2015: New approaches to improve predictive human safety testing (€10-15m)
- PHC 34 – 2014: eHealth interoperability (up to €1m)
Whew. That’s it. Worth noting that a whole bunch of these (PHCs 1, 5, 6, 10, 13, 17, 23 and 32) have a deadline in the very near future: 11th March 2014. Others (7, 8, 15, 19, 20, 26, 31, 34) have a slightly further deadline of April 15th 2014. There are also others that have deadlines in July and later.
Each of these schemes has a few tens of millions of Euros attached to it. It’s worth noting that the amounts (e.g. €4-6m) are indicative rather than mandatory. The evaluating committee will be looking at proposals with different costs too.
There are also a whole bunch of “coordination activities” listed in the supporting document.
Each of these has its own submission page, e.g. this one for PHC-05, which includes further information and application documents. For obvious reasons, I’m not listing all of them here!
Who it’s for:
Most of those require multiple companies to apply (usually 3, from different countries). Details of the application process can be found here. Some of the funding calls (those labelled “SME Instrument”) only require a single applicant.
You should look at this if you’re doing anything at all in this field. Many of those funding calls are straight, 100% funded grants, rather than the usual match-funded kind from Innovate UK (the EU is not restricted by its own Notified State Aid rules, since it’s not a state!). If your area of interest overlaps with one of the headings above, it’d be silly not to try and tap into some of this funding.
The first upcoming deadlines are very soon – 11th March and 15th April 2014 – so if this is of interest, get moving now!
If you are curious about R&D Tax Credits, Innovation Grants and Open CultureGET IN TOUCH
In 2013, the venture capitalist Aileen Lee coined the term ‘unicorn’ for a startup company valued at over $1 billion. The name was meant to reflect the extreme rarity of…
In recent years, Facebook has become synonymous with the concept of ‘Fake News’. From Macedonian teenagers influencing the American election to former executives speaking out against its effect on society,…
“Robots will steal our jobs” has become a common prediction. Whether people are angry or resigned to their fate, we seem to take it for granted that automation will create…
We treat automation in any industry with a healthy degree of suspicion. After all, many of our jobs are at risk in the not too distant future. A recent study…